FR2031807A5 - 17a-subst estratrienes - Google Patents

17a-subst estratrienes

Info

Publication number
FR2031807A5
FR2031807A5 FR6902940A FR6902940A FR2031807A5 FR 2031807 A5 FR2031807 A5 FR 2031807A5 FR 6902940 A FR6902940 A FR 6902940A FR 6902940 A FR6902940 A FR 6902940A FR 2031807 A5 FR2031807 A5 FR 2031807A5
Authority
FR
France
Prior art keywords
estratrienes
subst
thiocyanomethyl
acylmercapto
estratriene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR6902940A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jenapharm GmbH and Co KG
Original Assignee
Jenapharm GmbH and Co KG
VEB Jenapharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm GmbH and Co KG, VEB Jenapharm filed Critical Jenapharm GmbH and Co KG
Priority to FR6902940A priority Critical patent/FR2031807A5/fr
Application granted granted Critical
Publication of FR2031807A5 publication Critical patent/FR2031807A5/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
FR6902940A 1969-02-07 1969-02-07 17a-subst estratrienes Expired FR2031807A5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR6902940A FR2031807A5 (en) 1969-02-07 1969-02-07 17a-subst estratrienes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6902940A FR2031807A5 (en) 1969-02-07 1969-02-07 17a-subst estratrienes

Publications (1)

Publication Number Publication Date
FR2031807A5 true FR2031807A5 (en) 1970-11-20

Family

ID=9028799

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6902940A Expired FR2031807A5 (en) 1969-02-07 1969-02-07 17a-subst estratrienes

Country Status (1)

Country Link
FR (1) FR2031807A5 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2393008A1 (fr) * 1976-06-14 1978-12-29 Jenapharm Veb Procede pour la fabrication de nouveaux composes du type gonadiene-4,9(10)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2393008A1 (fr) * 1976-06-14 1978-12-29 Jenapharm Veb Procede pour la fabrication de nouveaux composes du type gonadiene-4,9(10)

Similar Documents

Publication Publication Date Title
SE402213B (sv) Konstgjord stoma for perkutan genomforing av i kroppen inopererade, langstreckta implantat
NO1994013I1 (no) Budenosid/ 16¿, 17¿-alkyldendioksypregna-1,4-dien-3,20-dioner
AU6074973A (en) Direct fixation rail fastener
ES421253A1 (es) Un procedimiento para la preparacion de nuevos 11,11-alco- hiliden-esteroides.
AU469971B2 (en) Waist support and hip girdle
IL38378A0 (en) Steroids of the androstane series and their preparation
IL45200A (en) 16 ,17 -cyclopentylidenedioxy-9 -fluoro-11 ,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate and anti-inflammatory compositions comprising it
DK139031B (da) Analogifremgangsmåde til fremstilling af i 21-stillingen alkylerede 3,20-dioxo-delta4-steroider af pregnanrækken.
FR2031807A5 (en) 17a-subst estratrienes
IE35013L (en) Injectable therapeutic compositions.
NL6901298A (en) 17a-subst estratrienes
BE749658A (fr) Procede de preparation de composes steroides substitues en position 17
CA1006156A (en) Steroids of the pregnane series
PH10088A (en) 2 b-hydroxy-3 l-amino steroids of the obstrane androstane and pregnane series
AU470180B2 (en) Absorbable copolymer suture
AR197216A1 (es) Procedimiento para producir 17,21-diacetato de 6alpha,9alpha-difluoro-11beta,17,21-trihidroxi-16beta-metil-pregna-1,4-dien-3,20-diona
ES415398A1 (es) Procedimiento para la preparacion de cianofenoxiacetonitri-los.
ES411969A1 (es) Procedimiento para la preparacion de una rifamicina 3-sus- tituida.
SE402914B (sv) Forfarande for framstellning av 6-metyl-2h-pyran-2,4 (3h)-dion-derivat med hypotensiv verkan
ES415479A1 (es) Procedimiento para preparar oxaprostaglandinas.
IL35598A (en) The manufacture of 4,6-dichloro-16-methylene-17alpha-hydroxy-pregna-4,6-diene-3,20-dione and the new 4,6-dichloro-16beta-chloromethyl-16alpha,17alpha-epoxy-pregna-4,6-diene-3,20dione
AU4145272A (en) 6alpha,9alpha-difluorosteroids of the pregnane series
GB568188A (en) Improvements in sectional roofing
IL38241A (en) 6alpha,16alpha-dimethyl-21-hydroxy-delta1,4-pregnadiene-3,20-diones
JPS51133677A (en) Time sharing multi-control system

Legal Events

Date Code Title Description
ST Notification of lapse